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Sentinels of DNA integrity 
in stem cells
Safeguarding future 
generations of cells
Integrated into the somatic cell cycle are multi-
faceted mechanisms to protect genomic fidelity 
from genotoxic threats occurring during cell divi-
sion or cellular quiescence. How embryonic stem 
cells respond to an array of attacks on genomic 
integrity has been uncertain, particularly in light of 
embryonic-like rapid cell cycle phases versus adult 
cells and the lack of an effective G1/S checkpoint. 
Whether a DNA damage response is activated 
similarly to somatic cells or apoptotic pathways 
used to purge damaged cells are important ques-
tions, since the longevity of embryonic stem cells 
provides opportunities for accumulated mutations 
and a source for carcinogenic cells. In this issue, 
Chuyikin et al. investigate the timing and sensi-
tivity of the DNA damage response pathway to 
double strand breaks (DSBs) in mouse embryonic 
stem cells (ESCs), validating its responsiveness 
and providing a comprehensive view of key 
signaling events. 
DNA DSBs are potently mutagenic lesions 
incurring chromosome breaks, potential rear-
rangements, mutation and loss of information.1 
The cellular response is immediate, sensitive 
and persistent, occurring within 30 seconds of 
damage upon detection of as little as 8 DSBs 
per cell. The response can be fully active in 15 
minutes and persist for hours. Repair is preferred 
and may elicit checkpoint delays to cell cycle 
progression, with extreme genotoxic conditions 
initiating apoptotic pathways. The majority of DSB 
proteins are activated by PI-3 like kinases, with the 
primary mammalian response to DSBs occurring 
via the ATM kinase that is able to respond directly 
to DSBs. Phosphorylated downstream targets 
include the uncommon histone, H2AX. This histone 
provides a cytological platform at DSB sites for the 
recruitment of DSB mediator and effector proteins 
such as MDC1 and NBS1. To this scaffold further 
DSB proteins are recruited, amplifying the signal. 
NBS1 is part of the MRN complex that includes 
MRE11 and Rad50 and mediates nuclear local-
ization of the complex to the DNA for stabilizing 
chromatin ends. The nucleolytic processing of 
DNA ends by MRE11 resection triggers a second 
pathway modulated by ATR, that responds to RPA 
coated ssDNA. Chuyikin et al., used antibodies to 
phosphorylated ATM and H2AX (pATM, pH2AX) 
as sensitive temporal markers of DNA repair 
foci that form at DSBs and followed these events 
through the cell cycle.
In fast proliferating undifferentiated cells an 
increase in single strand DNA breaks (SSBs) is 
typically observed, attributed to ongoing DNA 
replication, and not generally considered muta-
genic. Chuyikin et al. used sensitive comet assays 
along with pH2AX and pATM antibodies to 
confirm the presence of SSBs in mESCs and 
a low background of pH2AX positive/pATM 
absent poised foci. Upon γ-irradiation to induce 
DSBs, dramatic detection of DNA repair foci 
including both pH2AX and pATM occurs. FACs 
analysis indicated no cell cycle arrest at G1/S 
from γ-irradiation, although a slight delay at 
G2/M. Chuyikin et al. did find that mESCs have 
an active spindle assembly checkpoint allowing 
cells to be blocked at G2/M with nocodazole 
and then released synchronously through the cell 
cycle. The key to their detection of this checkpoint 
was a six hour treatment with drug, versus longer 
timepoints. Indeed Reider and Maiato2 have 
shown that in mammalian cells, spindle assembly 
checkpoint duration is variable and need not be 
satisfied to be overridden by adaptation, slippage 
or leakage, quite unlike the tight cell cycle arrest 
observed in fungi. Therefore longer treatments with 
nocodazole to arrest mESCs at this stage would 
be expected to simply be ineffective and promote 
further polyploidy by attenuating the mitotic mech-
anism. The authors detailed analysis of induction 
of DNA repair foci in all cell cycle stages revealed 
that all stages generate foci, including metaphase 
chromosomes in mitosis, although foci were most 
prominent in G1, G2 phases. Thus the primary 
response by the ATM pathway in these cells is not 
limited by cell cycle phase.
The maintenance of genomic fidelity in ESCs 
may require more enhanced DNA repair3 as 
well as alternative mechanisms to DNA repair, 
such as increased apoptosis. Chuyikin et al. 
observed increased caspase activity triggered 
after γ-irradiation of mESCs, but found no signifi-
cant increase in cell death. They also found that 
protein levels of p53, a downstream target of 
the ATM kinase that is important for the G1/S 
checkpoint as well as p53-dependent apoptosis, 
were comparable to fibroblast cells, however p53 
lacked activating phosphorylation. Both of these 
observations help to explain an ineffective G1/S 
checkpoint and the need for p53-independent 
apoptosis. 
Additional alternate mechanisms for main-
taining genomic integrity ESCs have been reported 
and contribute. This includes a 100X reduction in 
mutations versus somatic cells and resistance to 
oxidative stress. Asymmetry mechanisms,4 that 
are a commonly used means of cellular signaling 
and polarity from yeast to man may also apply, 
as in the Cairns immortal strand hypothesis. In 
1975 Cairns proposed that stem cells might 
minimize mutations to their genomes from DNA 
replication by asymmetric segregation of their 
DNA. Retention of parental strands in the stem cell 
and segregation of potential mutation carrying 
DNAs into non-stem cell or differentiating daugh-
ters could reduce the mutation potential.4 Such 
asymmetric sister chromatid strand segregation is 
still controversial despite having been observed 
during mitosis in several stem cell populations. 
Continued elegant studies, such at that by Chuyikin 
et al., that define which pathways are present and 
examine the crosstalk in pathways used to detect, 
signal, repair and protect genomic integrity will 
continue to provide exciting new systemic views 
into stem cells. Our therapeutic use of stem cells 
in the future including understanding of cellular 
differentiation and cancer depends on it. 
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Protein kinases coordinately 
regulate the p53
ΔNp63α axis after DNA 
damage
The ancestral member of the p53 gene family, 
p63, is overexpressed in head and neck squamous 
cell carcinomas (HNSCC). To date little is known 
about the regulation of the N-terminal truncated 
isoform of p63 (ΔNp63α) which is considered a 
marker of certain epithelial stem cells and cancer 
stem cells. In this issue of Cell Cycle, a study 
provides insight into the DNA-damage induced 
post-translational regulation of ΔNp63α protein 
stability by the ATM pathway. The data imply that 
ATM has evolved to act as a master regulator in 
the basal skin stem cell to co-ordinately switch 
off ΔNp63α and switch on p53 after irradiation. 
This would attenuate the proliferative capacity 
of the stem cell in order for DNA damage to be 
repaired by the p53 response. These data also 
have implications for how inactivation of the 
ATM pathway could promote carcinogenesis in 
squamous cancers via upregulation of ΔNp63α 
and for developing novel therapeutic strategies 
for inhibiting ΔNp63α in cancer stem cell popula-
tions.
Protein kinase control of p53: Phosphorylation 
activates p53. Regulation of the p53 tumor 
suppressor protein involves sets of post-transla-
tional modifications, including phosphorylation, 
acetylation, and ubiquitination, which mediate 
p53 protein stability and activational status.1 
Biochemical and genetic studies have together 
solved the functions of some p53 kinase path-
ways.2 For example, ATM is the pre-dominating 
genetic activating factor for p53, but how 
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tion, it is possible that the enhanced production 
of ΔNp63α in cancer stem cells occurs via a 
defect in protein kinase-mediated degradation of 
ΔNp63α. Accordingly, strategies that promote, for 
example, ATM-mediated degradation of ΔNp63α 
in cancer stem cells may yield novel therapeu-
tics that enable us to directly target the root of 
squamous cell carcinomas. 
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in stimulating p53 function after irradiation,15 this 
kinase pathway might also coordinate p53 acti-
vation and ΔNp63α protein degradation. These 
data together suggest that at least two protein 
kinase pathways play dual roles in controlling 
p53 family function after DNA damage. 
Implications of ATM regulation of ΔNp63α 
in cancer. There is increasing evidence that 
cancer is a stem cell disease. Adult stem cells 
are long lived cells that are able to accumulate 
the number of genetic mutations necessary to 
result in tumor formation. It is conceivable that 
overexpression of genes which maintain stem 
cells, and subsequently cancer stem cells, with 
a proliferative advantage would be beneficial 
to the establishment and progression of cancer. 
Studies indicate that ΔNp63α is specifically 
expressed in epidermal stem cells possessing the 
highest proliferative capacity, and that ΔNp63α 
expression is lost as these cells migrate from the 
basal layer and become terminally differentiated 
cells.10 Subsequently, p63 has been shown to be 
essential for maintaining the proliferative capacity 
of epidermal stem cells and preventing premature 
entry into terminal differentiation.10 Parallel and 
p63-independent functions are carried out in other 
stem cell compartments, for example Bmi-111 and 
Plzf12 are essential for maintaining the prolifera-
tive potential of hematopoietic and spermatogenic 
stem cells, respectively. Hence, maintaining a 
state of high proliferative potential appears to be 
a common strategy to avert differentiation and 
enable extensive programmes of cell division. 
Therefore overexpression of these factors which 
maintain proliferation and prevent differentiation 
may be of selective advantage to cancer stem 
cells. 
Head and neck squamous cell carcinomas 
are malignancies derived from cells within the 
basal epithelia of the aerodigestive mucosa and 
are usually treated with a combination of irradia-
tion and chemotherapy.13 The majority of head 
and neck tumors harbour inactivating mutations 
affecting the p53 gene13 indicating that selection 
pressures have been placed on p53 pathway 
silencing. However, the most ancient member 
of the p53 gene family, p63, has also been 
implicated in squamous cancers.13 Although the 
primary function of p63 gene family function 
is in ectodermal differentiation during devel-
opment and stratified epithelial progenitor cell 
maintenance, the over-expression of ΔNp63α is 
observed in numerous squamous cell carcinomas, 
including head and neck, lung, prostate, bladder 
and breast, suggesting that p63 can act as an 
oncogene.5 In fact, ΔNp63 can transcriptionally 
up-regulate proteins implicated in pro-survival 
pathways including Heat shock protein 70 
(hsp70), Multi Drug Resistant gene 1 (MDR1), the 
epidermal growth factor receptor (EGFR), and the 
integrin family,14 providing a mechanism for the 
pro-proliferative functions of this isoform in stem 
cells and in cancers. As this issue of Cell Cycle 
has illustrated that specific post-translational modi-
fications of ΔNp63α via ATM and related kinase 
activities are associated with ΔNp63α degrada-
ATM phosphorylation of p53 alters its function 
biochemically is not so well-defined. By contrast, 
phosphorylation of the C-terminal CK2-site of 
p53 stabilizes p53:DNA interactions, phospho-
rylation of the CK2 site on p53 is induced upon 
irradiation, and alanine substituted CK2-site p53 
transgenic mice have elevated damage-induced 
bladder cancer and UV-induced skin cancer.3 
Clinical studies have subsequently shown that the 
UV-induced phosphorylation of p53 at the CK2 
site is confined to the basal or stem-cell compart-
ment in human skin rather than the suprabasal 
layer where p53 protein is predominantly stabi-
lized after DNA damage.4 These data highlight 
the cell-specificity in kinase catalyzed activation 
of the p53 tumor suppressor function and also the 
intriguing possibility that skin stem cell populations 
have evolved the recruitment of specific kinase 
pathways to maintain stem cell genome integrity. 
Protein kinase control of ΔNp63: 
Phosphorylation destabilizes ΔNp63. The p53 
gene has evolved from an ancestral mother gene 
named p63.5 The structure of the p63 gene is very 
similar to that of p53, consisting of an N-terminal 
transactivation (TA) domain, a highly conserved 
core DNA-binding domain and a C-terminal 
oligomerization domain. The p63 gene contains 
an internal promoter leading to the expression 
of a transcriptionally active (TA) isoform and an 
N-terminally truncated (ΔN) protein isoform named 
ΔNp63α, which can function as a transcription 
factor in its own rite. p63 knockout mice have 
severe developmental defects, including abnormal 
development of limbs, stratified epidermis and 
epidermal tissues, and die shortly after birth.5 
Particularly relevant to the phosphorylation of 
p53 in damaged skin stem cells, the expression of 
ΔNp63α is restricted to the basal compartment of 
the stratified epithelia, suggesting a role in main-
taining the proliferative compartment.6 
The expression of these two p53 family 
members in basal cell populations raises the 
question of whether regulation of the pro-prolifer-
ative ΔNp63α and anti-proliferative p53 protein 
pathways are co-ordinated after DNA damage; 
i.e. ΔNp63α protein is de-stabilized after DNA 
damage using in vitro and in vivo systems7,4 whilst 
upregulation of p53 phosphorylation occurs at the 
CK2 and ATM sites in basal skin cells in vivo.4 
Is there a kinase pathway that could both switch 
ΔNp63α off and p53 on when the stem cells need 
to maintain genome stability after DNA damage? 
A paper in this issue of Cell Cycle (Haung et 
al., 2008) addresses this question revealing that 
ΔNp63α is sequentially phosphorylated after DNA 
damage by ATM, CDK2 and p70s6K. This DNA 
damage induced phosphorylation of ΔNp63α 
leads to a dramatic decrease in ΔNp63αprotein 
levels in HNSCC cells, which is abated in the 
absence of these protein kinases.8 Although the 
biochemical effects of each phosphorylation on 
ΔNp63α protein degradation is not defined, 
these data provide a co-ordinated mechanism for 
switching ΔNp63α off and p53 on involving the 
known p53 activator, ATM, as the master switch in 
this axis.9 Similarly, as CDK2 has been implicated 
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